AMANDA ATCHESON: Open Payments
NPI 1982203329 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 2 | $144 |
| Amgen Inc. | 2 | $143 |
| Boston Scientific Corporation | 1 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $116 |
| Novartis Pharmaceuticals Corporation | 2 | $84 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $38 |
| AtriCure, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: Attruby, WATCHMAN FLX, JARDIANCE, LEQVIO, LifeVest, SYNERGY ABLATION SYSTEM, REPATHA, FARXIGA.
Industry payments across AL — which companies pay providers there.
